Pfizer Inc. has issued a substantial recall for its Lo/Ovral and Norgestrel birth control tablets following the revelation that their pill sequencing is incorrect and may not properly protect women against becoming pregnant.
The pharma company announced this morning that it had voluntarily recalled 14 lots of Lo/Ovral®-28 (norgestrel and ethinyl estradiol) Tablets, as well as 14 lots of Norgestrel and Ethinyl Estradiol Tablets (the generic brand) in the U.S. market. The birth control drugs were pulled off the shelves after any investigation by Pfizer found that “some blister packs may contain an inexact count of inert or active ingredient tablets and that the tablets may be out of sequence,” according to the company’s press release.
Packages for both defective birth control medications are supposed to contain 21 tablets of active ingredients and seven tablets of inert ingredients that only prevent pregnancy most effectively when taken in the right sequence. Because the tablets may be out of sequence, the daily regimen of the pills may not be correct and therefore may make women who take the medications more susceptible to an unplanned pregnancy.
These tablets were manufactured and packaged by Pfizer Inc., labeled under the Akrimax Pharmaceuticals brand, and distributed to warehouses, clinics and retail pharmacies nationwide.
If you or a loved one has been victimized by a defective drug, there may be legal grounds for a lawsuit. Call Sokolove Law today for a free legal consultation and to see if a dangerous drug lawsuit may be a possibility.